-
Analyst Opinions
NewNew Prescription – Generative AI Meets Healthcare (Vol. 2)
GlobalData's latest Innovation Radar report "New Prescription: Generative AI Meets Healthcare (Vol. 2)," expands upon its predecessor and digs further into the transformative capabilities of generative AI within the pharmaceutical and healthcare sectors. This volume dives into recent real-world applications where generative AI is advancing across drug discovery, diagnostics, clinical documentation, and patient support. From harnessing vast datasets to expediting R&D breakthroughs and refining patient care through lifelike speech synthesis, this report unveils the ongoing evolution of generative AI in...
-
Product Insights
NewAccenture Plc Partner Ecosystem Profile
GlobalData's new report titled "Accenture Plc Partner Ecosystem Profile " serves as a crucial resource for analyzing the partner landscape of Accenture Plc. It identifies the company's partners across various countries and regions, and tracks over 70 data fields including IT solution areas of interest, business fundamental data (such as revenue and employee bands), partner engagement signing country, focused verticals, and more.It is based on data and information gathered from a range of sources including company websites, press releases, CXO...
-
Product Insights
NewCisco Systems Inc. Partner Ecosystem Profile
GlobalData's new report titled "Cisco Systems Inc. Partner Ecosystem Profile " serves as a crucial resource for analyzing the partner landscape of Cisco Systems Inc.. It identifies the company's partners across various countries and regions, and tracks over 70 data fields including IT solution areas of interest, business fundamental data (such as revenue and employee bands), partner engagement signing country, focused verticals, key executive details, and more.It is based on data and information gathered from a range of sources including...
-
Analyst Opinions
NewAI Compute – How Chips Drive Next Industrial Leap
AI Chips Trend Analysis Report Overview GlobalData's "AI Compute: How Chips Drive Next Industrial Leap," innovation radar report explores the transformative impact of semiconductor chip innovations, particularly AI chips, across various industries such as healthcare, telecom, and energy & utilities. The report illuminates how advanced chips are enhancing computational power, enabling improved analytics, and driving automation. By reshaping industrial processes, these technologies are boosting efficiency and fostering innovation. The “AI Compute” report provides strategic insights to help businesses capitalize on...
-
Product Insights
NewLikelihood of Approval Analysis for Pneumovirus Infections
Overview How likely is it that the drugs in Pneumovirus Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pneumovirus Infections Overview Pneumoviridae is a family of negative-strand RNA viruses in...
-
Product Insights
NewLikelihood of Approval Analysis for Orthohepadnavirus Infections
Overview How likely is it that the drugs in Orthohepadnavirus Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Orthohepadnavirus Infections Overview Orthohepadnavirus is a genus of viruses, in the family...
-
Product Insights
NewLikelihood of Approval Analysis for Anemia
Overview How likely is it that the drugs in Anemia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anemia Overview Anemia is a condition characterized by insufficient healthy red blood cells...
-
Product Insights
NewLikelihood of Approval Analysis for Nociceptive Pain
Overview How likely is it that the drugs in Nociceptive Pain will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Nociceptive Pain Overview Nociceptive pain is a type of pain caused by...
-
Product Insights
NewLikelihood of Approval Analysis for Neutropenia
Overview How likely is it that the drugs in Neutropenia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Neutropenia Overview Neutropenia is an abnormally low concentration of neutrophils (a type of...
-
Sector Analysis
Company Filings Analytics – Trends & Signals 2023
The Filings Trends and Signals report analyzes earnings call transcripts and annual reports for trends and signals from popular geographies, themes, companies, and topics. The in-depth analysis enables businesses to make more informed decisions by leveraging competitive intelligence. The report also provides proxy insights and comparative analytics for companies to compare their own performance and actions against industry peers and competitors. It provides a valuable benchmark for evaluating business drivers, assessing risks, understanding significant events, and analyzing corporate actions. The...